Diagnostic and therapeutic issues for patients with advanced nonsmall cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (Review)

By        

International Journal of Oncology, Vol. 45, Iss. 2, 2014-01 ,pp. : 509-515

Spandidos Publications

Access to resources Recommend Favorite

Response to alectinib after one year of discontinuation of crizotinib in anaplastic lymphoma kinase-positive non-small-cell lung cancer: A case report

By                  

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 889-891

Science Publishers

Access to resources Recommend Favorite

Erratum to: Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma

By Morales La Madrid Andres   Campbell Nicholas   Smith Sonali   Cohn Susan   Salgia Ravi  

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 301-301

Springer Publishing Company

Access to resources Recommend Favorite

Anaplastic large cell lymphoma with primary involvement of the skeletal muscle: A case report

By                  

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2815-2818

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of NPM-ALK by siRNA Causes Anaplastic Large Cell Lymphoma Cell Growth Inhibition and Augments the Anti Cancer Effects of Chemotherapy In Vitro

By Hsu Faye Yuan-yi   Zhao Yi   Anderson W. French   Johnston Patrick B.  

Cancer Investigation, Vol. 25, Iss. 4, 2007-06 ,pp. : 240-248

Informa Healthcare

Access to resources Recommend Favorite